Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.828 USD | +2.86% | +3.83% | -71.67% |
15/03 | North American Morning Briefing : Inflation -2- | DJ |
14/03 | Top Midday Decliners | MT |
Sales 2024 * | 4.6M 384M | Sales 2025 * | 1.3M 108M | Capitalization | 33.13M 2.76B |
---|---|---|---|---|---|
Net income 2024 * | -49M -4.09B | Net income 2025 * | -60M -5.01B | EV / Sales 2024 * | -2.38 x |
Net cash position 2024 * | 44.1M 3.68B | Net cash position 2025 * | 89.5M 7.47B | EV / Sales 2025 * | -43.4 x |
P/E ratio 2024 * |
-0.69
x | P/E ratio 2025 * |
-0.8
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.37% |
Latest transcript on Spruce Biosciences, Inc.
1 day | -3.33% | ||
1 week | +6.74% | ||
Current month | +13.70% | ||
1 month | +9.35% | ||
3 months | -82.19% | ||
6 months | -25.46% | ||
Current year | -72.53% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 03/22/03 | |
Samir Gharib
DFI | Director of Finance/CFO | 41 | 01/20/01 |
Michael Grey
CHM | Chairman | 71 | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Spiegelman
BRD | Director/Board Member | 65 | 09/20/09 |
Michael Grey
CHM | Chairman | 71 | 01/17/01 |
Tiba Aynechi
BRD | Director/Board Member | 48 | 01/16/01 |
Date | Price | Change | Volume |
---|---|---|---|
14/24/14 | 0.835 | +3.73% | 93 225 |
13/24/13 | 0.805 | -3.33% | 534,351 |
10/24/10 | 0.8327 | -0.68% | 243,215 |
09/24/09 | 0.8384 | -0.84% | 740,123 |
08/24/08 | 0.8455 | +5.75% | 735,242 |
Delayed Quote Nasdaq, May 14, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-72.53% | 33.13M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+44.93% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- SPRB Stock